Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 8 results found. Search for [ AbCellera ]

Results 1 to 8 of 8
Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


Reuters
October 9, 2020
Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


PB Jayakumar
June 11, 2020
While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks


Reuters
June 11, 2020
Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said


BusinessToday.In
New Delhi, June 3, 2020
The experimental treatment, LY-CoV555, has been developed through collaboration with privately held AbCellera Biologics, which Lilly partnered with in March


PB Jayakumar
April 29, 2020
Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest antigen therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit


PAGES 1 OF 1